Free Trial

Concord Medical Services (CCM) Competitors

Concord Medical Services logo
$5.08 -0.17 (-3.14%)
Closing price 10/24/2025 03:55 PM Eastern
Extended Trading
$5.04 -0.04 (-0.88%)
As of 10/24/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CCM vs. BNR, CORBF, PIII, ATPC, BDSX, BMGL, MGRX, MRAI, BRTX, and BGLC

Should you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include Burning Rock Biotech (BNR), Global Cord Blood (CORBF), P3 Health Partners (PIII), Agape ATP (ATPC), Biodesix (BDSX), Basel Medical Group (BMGL), Mangoceuticals (MGRX), Marpai (MRAI), Biorestorative Therapies (BRTX), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry.

Concord Medical Services vs. Its Competitors

Concord Medical Services (NYSE:CCM) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

In the previous week, Burning Rock Biotech had 2 more articles in the media than Concord Medical Services. MarketBeat recorded 3 mentions for Burning Rock Biotech and 1 mentions for Concord Medical Services. Burning Rock Biotech's average media sentiment score of 0.83 beat Concord Medical Services' score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Concord Medical Services Neutral
Burning Rock Biotech Positive

Concord Medical Services has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -26.04%. Concord Medical Services' return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Concord Medical ServicesN/A N/A N/A
Burning Rock Biotech -26.04%-23.61%-15.73%

Concord Medical Services has higher earnings, but lower revenue than Burning Rock Biotech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Medical Services$52.60M0.42-$42.23MN/AN/A
Burning Rock Biotech$70.67M1.99-$47.49M-$1.90-6.87

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concord Medical Services
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Burning Rock Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

30.0% of Burning Rock Biotech shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Concord Medical Services has a beta of -1.04, suggesting that its share price is 204% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Summary

Burning Rock Biotech beats Concord Medical Services on 6 of the 11 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCM vs. The Competition

MetricConcord Medical ServicesMED IndustryMedical SectorNYSE Exchange
Market Cap$22.10M$3.68B$6.22B$22.11B
Dividend YieldN/A1.11%5.72%3.55%
P/E RatioN/A13.0131.5033.37
Price / Sales0.421.26594.9261.75
Price / CashN/A17.7337.2524.64
Price / Book0.104.0112.054.66
Net Income-$42.23M$38.94M$3.34B$1.02B
7 Day Performance-6.27%-0.48%1.93%2.22%
1 Month Performance-19.29%-1.02%7.77%2.07%
1 Year Performance-33.62%10.72%56.40%14.05%

Concord Medical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCM
Concord Medical Services
0.3296 of 5 stars
$5.09
-3.1%
N/A-34.1%$22.10M$52.60M0.00970Analyst Forecast
Gap Down
BNR
Burning Rock Biotech
0.8495 of 5 stars
$8.49
-1.2%
N/A+358.2%$91.35M$70.67M-4.471,390News Coverage
Analyst Forecast
Gap Up
CORBF
Global Cord Blood
N/A$0.75
flat
N/A-40.0%$91.16M$196.12M0.001,200
PIII
P3 Health Partners
3.0201 of 5 stars
$8.99
+3.9%
$16.25
+80.8%
-59.8%$64.63M$1.50B-0.20500Analyst Forecast
ATPC
Agape ATP
0.5444 of 5 stars
$1.22
-0.8%
N/A-18.7%$61.01M$1.32M-2.9840News Coverage
Analyst Forecast
Gap Down
BDSX
Biodesix
3.5784 of 5 stars
$7.79
+5.3%
$32.50
+317.2%
-79.4%$57.10M$71.32M-1.34220Analyst Forecast
BMGL
Basel Medical Group
N/A$1.57
+3.3%
N/AN/A$28.97MN/A0.0036Analyst Forecast
MGRX
Mangoceuticals
1.9723 of 5 stars
$2.62
+3.6%
N/A-5.3%$27.62M$620K-0.683
MRAI
Marpai
N/A$1.47
+11.4%
N/A+195.0%$26.91M$34.87M-0.56150
BRTX
Biorestorative Therapies
1.539 of 5 stars
$1.61
+0.6%
N/A-0.6%$12.85M$400K-1.277Analyst Forecast
BGLC
BioNexus Gene Lab
0.5187 of 5 stars
$5.05
-5.4%
N/A+30.9%$9.09M$9.51M0.0030News Coverage
Gap Down

Related Companies and Tools


This page (NYSE:CCM) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners